Efficacy and safety of brexpiprazole in early-episode schizophrenia: post hoc analysis of Phase 3 clinical trials in adults and adolescents
This analysis expands the evidence base for brexpiprazole in schizophrenia by demonstrating efficacy in patients who are early in their disease course. The safety profile of brexpiprazole was consistent with previous clinical trials.
Authors
- Anton Palma
- Brian K. Pflug
- Christoph U. Correll
- Zhen Zhang
- Tim Pham
- Murat Yildirim
Institutions
- Lundbeck (Denmark) (DK)
- Otsuka (United States) (US)
- German Centre for Cardiovascular Research (DE)
- Otsuka (United Kingdom) (GB)
Publication Details
- Journal
- Psychiatry Research
- Published
- 2026-03-12
- DOI
- https://doi.org/10.1016/j.psychres.2026.117091
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00